Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
IPO Year:
Exchange: NASDAQ
Website: optioncarehealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/4/2024 | $27.00 | Buy → Neutral | Goldman |
| 10/31/2024 | $38.00 → $26.00 | Buy → Hold | Jefferies |
| 10/30/2024 | $43.00 → $29.00 | Buy → Neutral | BofA Securities |
| 7/16/2024 | $36.00 | Mkt Outperform | JMP Securities |
| 2/27/2023 | $38.00 | Buy | Jefferies |
| 8/4/2021 | $22.00 → $24.00 | Buy | Canaccord Genuity |
| 7/19/2021 | $20.00 → $25.00 | Neutral → Buy | Goldman Sachs |
NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and
New Board Brings Significant and Diverse Experience to Support Company's Growth and Success Riverbed|Aternity (the "Company") today announced that, as part of its recapitalization, which was finalized today, the following seven directors have been appointed to the Company's new Board of Directors (the "Board"). These appointments became effective on December 7, 2021, upon the completion of the Company's recapitalization and voluntary court-supervised process. "We are pleased to welcome our new directors, a group of seasoned, accomplished and respected business leaders who will bring a wide and diverse range of skills to the Riverbed|Aternity Board," said Dan Smoot, President and CEO of Ri
BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health")(NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, supe
JMP Securities analyst Constantine Davides initiates coverage on Option Care Health (NASDAQ:OPCH) with a Market Outperform rating and announces Price Target of $36.
Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:OPCH) with a Outperform and maintains $38 price target.
Option Care Health (NASDAQ:OPCH) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.23 by 13.04 percent. This is a 23.81 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $1.146 billion which beat the analyst consensus estimate of $1.102 billion by 4.02 percent. This is a 12.82 percent increase over sales of $1.016 billion the same period last year.
Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion. • MSCI (NYSE:MSCI) is expected to report quarterly earnings at $3.45 per share on revenue of $684.13 million. • Quest Diagnostics (NYSE:DGX) is expected to report quarterly earnings at $1.85 per share on revenue of $2.29 billion. • Community Bank System (NYSE:CBU) is expected to report quarterly earnings at $0.78 per share on revenue of $176.83 million. • Herc Hldgs (NYSE:HRI) is estimated to report quarterly earnings at $2.15 per share on revenue of $782.85 million. • JetBlue Airways (NASDAQ:JBLU) is expected to report quarterly loss at $0.52 p
Jefferies analyst Brian Tanquilut maintains Option Care Health (NASDAQ:OPCH) with a Buy and raises the price target from $36 to $38.
Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:OPCH) with a Outperform and raises the price target from $35 to $38.
10-Q - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
S-8 - Option Care Health, Inc. (0001014739) (Filer)
10-Q - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
10-Q - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
Goldman downgraded Option Care Health from Buy to Neutral and set a new price target of $27.00
Jefferies downgraded Option Care Health from Buy to Hold and set a new price target of $26.00 from $38.00 previously
BofA Securities downgraded Option Care Health from Buy to Neutral and set a new price target of $29.00 from $43.00 previously
JMP Securities initiated coverage of Option Care Health with a rating of Mkt Outperform and set a new price target of $36.00
Jefferies resumed coverage of Option Care Health with a rating of Buy and set a new price target of $38.00
Canaccord Genuity reiterated coverage of Option Care Health with a rating of Buy and set a new price target of $24.00 from $22.00 previously
Goldman Sachs upgraded Option Care Health from Neutral to Buy and set a new price target of $25.00 from $20.00 previously
Barrington Research upgraded Option Care Health from to Outperform and set a new price target of $24.00 from $19.00 previously
Canaccord Genuity reiterated coverage of Option Care Health with a rating of Buy and set a new price target of $24.00 from $20.00 previously
Deutsche Bank Aktiengesellschaft reiterated coverage of Option Care Health with a rating of Buy and set a new price target of $23.50 from $22.00 previously
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
BANNOCKBURN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference, being held in London, on Tuesday, November 19, 2024, including a fireside chat at 8:30am GMT/3:30am ET.Bank of America Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 3, 2024, including a presentation at 8:50am ET.Bank of America Home Care Conference, being held virtually, on Monday, December 9, 2024, including a fireside chat at 11:10am ET. Webcast li
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results and Highlights Net revenue of $1,278.5 million, up 17.0% compared to $1,093.0 million in the third quarter of 2023Gross profit of $256.7 million, or 20.1% of net revenue, up 1.0% compared to $254.3 million, or 23.3% of net revenue, in the third quarter of 2023Net income of $53.9 million, or $0.31 diluted earnings per share, down 4.3% compared to net inco
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI08e5c12fc6d744c2bb159e0e3b1ebbc4. The call can also be accessed via a live
BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023Gross profit of $249.4 million, or 20.3% of net revenue, down 0.6% compared to $250.8 million, or 23.5% of net revenue, in the second quarter of 2023Net income of $53.0 million, or $0.30 diluted earnings per share, down 53.6% compared to ne
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BId5e0db240b9c416cbbdba9d2afe4b745. The call can also be accessed via a live audio w
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The William Blair 44th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 4, 2024, including a presentation at 12:00pm CT.The Jefferies Global Healthcare Conference, being held in New York, on Wednesday, June 5, 2024, including a fireside chat at 8:00am ET.The Goldman Sachs 45th Annual Global Healthcare Conference, being held in Miami, on Tuesday, June 11, 2024, including a fireside chat at 3:20pm
BANNOCKBURN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the BofA Securities Health Care Conference, being held in Las Vegas, on Tuesday, May 14, 2024, including a fireside chat presentation at 2:20pm PT. The webcast will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to eleva
BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net revenue, up 4.1% compared to $229.0 million, or 22.5% of net revenue, in the first quarter of 2023Net income of $44.8 million, or $0.26 earnings per share, up 14.2% compared to net income of $39.2
BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI1d47a2dd2eb24c8babfdf764749adc92. The call can also be accessed via a live audio w
NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results and Highlights Net revenue of $1,278.5 million, up 17.0% compared to $1,093.0 million in the third quarter of 2023Gross profit of $256.7 million, or 20.1% of net revenue, up 1.0% compared to $254.3 million, or 23.3% of net revenue, in the third quarter of 2023Net income of $53.9 million, or $0.31 diluted earnings per share, down 4.3% compared to net inco
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI08e5c12fc6d744c2bb159e0e3b1ebbc4. The call can also be accessed via a live
BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023Gross profit of $249.4 million, or 20.3% of net revenue, down 0.6% compared to $250.8 million, or 23.5% of net revenue, in the second quarter of 2023Net income of $53.0 million, or $0.30 diluted earnings per share, down 53.6% compared to ne
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BId5e0db240b9c416cbbdba9d2afe4b745. The call can also be accessed via a live audio w
BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net revenue, up 4.1% compared to $229.0 million, or 22.5% of net revenue, in the first quarter of 2023Net income of $44.8 million, or $0.26 earnings per share, up 14.2% compared to net income of $39.2
BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI1d47a2dd2eb24c8babfdf764749adc92. The call can also be accessed via a live audio w
BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BIc379f170a12b404ca1a244e8b51e9a3e. The call can also be access
BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results and Highlights Net revenue of $1,093.0 million, up 7.1% compared to $1,020.9 million in the third quarter of 2022Gross profit of $254.3 million, or 23.3% of net revenue, up 16.6% compared to $218.0 million, or 21.4% of net revenue, in the third quarter of 2022Net income of $56.3 million, or $0.31 basic earnings per share, up 45.0% compared to net income
BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI0632b6a55aed445b9372f4c32dd59b5b. The call can also be accessed via a live
BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Results and Highlights Net revenue of $1,069.1 million, up 9.0% compared to $980.8 million in the second quarter of 2022Gross profit of $250.8 million, or 23.5% of net revenue, up 15.6% compared to $216.9 million, or 22.1% of net revenue, in the second quarter of 2022Net income of $114.4 million, or $0.64 basic earnings per share, up 237.2% compared to net income o